(State or other jurisdiction of incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) | ||||||||||||
(Address of principal executive offices) | (Zip Code) | |||||||||||||
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |||||
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |||||
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |||||
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | |||||
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
| As of March 31, 2023 | |||||||||||||||||
| As Previously Reported | Adjustment | As Restated | |||||||||||||||
| Stockholders' equity: | |||||||||||||||||
| Accumulated deficit | $ | (562,457) | $ | (18,948) | $ | (581,405) | |||||||||||
| Accumulated other comprehensive income (loss) | (178) | 18,948 | 18,770 | ||||||||||||||
| Total stockholders' equity | 327,389 | — | 327,389 | ||||||||||||||
| Total liabilities and stockholders' equity | $ | 937,997 | $ | — | $ | 937,997 | |||||||||||
| Three Months Ended March 31, 2023 | |||||||||||||||||
| As Previously Reported | Adjustment | As Restated | |||||||||||||||
| Other income (expense): | |||||||||||||||||
| Interest expense | $ | (10,454) | $ | 2,373 | $ | (8,081) | |||||||||||
| Other income (expense), net | 21,899 | (21,321) | 578 | ||||||||||||||
| Total other income (expense) | 11,445 | (18,948) | (7,503) | ||||||||||||||
| Income (loss) before provision for income taxes | 8,182 | (18,948) | (10,766) | ||||||||||||||
| Net income (loss) | $ | 8,018 | $ | (18,948) | $ | (10,930) | |||||||||||
| Net loss per share, basic and diluted | $ | 0.07 | $ | (0.16) | $ | (0.09) | |||||||||||
| Other comprehensive income (loss): | |||||||||||||||||
| Change in cash flow hedge | $ | — | $ | (2,088) | $ | (2,088) | |||||||||||
| Amortization of dedesignated cash flow hedge | — | (2,373) | (2,373) | ||||||||||||||
| Total other comprehensive loss | (32) | (4,461) | (4,493) | ||||||||||||||
| Comprehensive income (loss) | $ | 7,986 | $ | (23,409) | $ | (15,423) | |||||||||||
| As Previously Reported | |||||||||||||||||
| Accumulated Deficit | Accumulated Other Comprehensive Income | Total Stockholders' Equity | |||||||||||||||
| Balance at December 31, 2022 | $ | (570,475) | $ | 23,263 | $ | 334,869 | |||||||||||
| Net income | 8,018 | — | 8,018 | ||||||||||||||
| Change in cash flow hedge | — | (23,409) | (23,409) | ||||||||||||||
| Amortization of dedesignated cash flow hedge | — | — | — | ||||||||||||||
| Balance at March 31, 2023 | $ | (562,457) | $ | (178) | $ | 327,389 | |||||||||||
| Adjustment | |||||||||||||||||
| Accumulated Deficit | Accumulated Other Comprehensive Income (Loss) | Total Stockholders' Equity | |||||||||||||||
| Balance at December 31, 2022 | $ | — | $ | — | $ | — | |||||||||||
| Net loss | (18,948) | — | (18,948) | ||||||||||||||
| Change in cash flow hedge | — | 21,321 | 21,321 | ||||||||||||||
| Amortization of dedesignated cash flow hedge | — | (2,373) | (2,373) | ||||||||||||||
| Balance at March 31, 2023 | $ | (18,948) | $ | 18,948 | $ | — | |||||||||||
| As Restated | |||||||||||||||||
| Accumulated Deficit | Accumulated Other Comprehensive Income (Loss) | Total Stockholders' Equity | |||||||||||||||
| Balance at December 31, 2022 | $ | (570,475) | $ | 23,263 | $ | 334,869 | |||||||||||
| Net loss | (10,930) | — | (10,930) | ||||||||||||||
| Change in cash flow hedge | — | (2,088) | (2,088) | ||||||||||||||
| Amortization of dedesignated cash flow hedge | — | (2,373) | (2,373) | ||||||||||||||
| Balance at March 31, 2023 | $ | (581,405) | $ | 18,770 | $ | 327,389 | |||||||||||
| Three Months Ended March 31, 2023 | |||||||||||||||||
| As Previously Reported | Adjustment | As Restated | |||||||||||||||
| Net income (loss) | $ | 8,018 | $ | (18,948) | $ | (10,930) | |||||||||||
| Change in operating assets and liabilities: | |||||||||||||||||
| Unrealized loss (gain) on derivative contracts | (19,623) | 21,321 | 1,698 | ||||||||||||||
| Amortization of dedesignated cash flow hedge | — | (2,373) | (2,373) | ||||||||||||||
| Exhibit No. | Description | |||||||
| 99.1 | ||||||||
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | |||||||
| Traeger, Inc. | |||||||||||
Date: August 7, 2023 | By: | /s/ Dominic Blosil | |||||||||
| Dominic Blosil | |||||||||||
| Chief Financial Officer | |||||||||||

| June 30, 2023 | December 31, 2022 | ||||||||||
| (unaudited) | |||||||||||
| ASSETS | |||||||||||
| Current Assets | |||||||||||
| Cash and cash equivalents | $ | 14,496 | $ | 39,055 | |||||||
| Restricted cash | — | 12,500 | |||||||||
| Accounts receivable, net | 83,290 | 42,050 | |||||||||
| Inventories | 97,803 | 153,471 | |||||||||
| Prepaid expenses and other current assets | 29,842 | 27,162 | |||||||||
| Total current assets | 225,431 | 274,238 | |||||||||
| Property, plant, and equipment, net | 52,274 | 55,510 | |||||||||
| Operating lease right-of-use assets | 11,284 | 13,854 | |||||||||
| Goodwill | 74,725 | 74,725 | |||||||||
| Intangible assets, net | 491,700 | 512,858 | |||||||||
| Other non-current assets | 14,231 | 15,530 | |||||||||
| Total assets | $ | 869,645 | $ | 946,715 | |||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||||||
| Current Liabilities | |||||||||||
| Accounts payable | $ | 18,563 | $ | 29,841 | |||||||
| Accrued expenses | 49,094 | 52,295 | |||||||||
| Line of credit | 40,000 | 11,709 | |||||||||
| Current portion of notes payable | 250 | 250 | |||||||||
| Current portion of operating lease liabilities | 4,109 | 5,185 | |||||||||
| Current portion of contingent consideration | 13,110 | 12,157 | |||||||||
| Other current liabilities | 2,143 | 1,470 | |||||||||
| Total current liabilities | 127,269 | 112,907 | |||||||||
| Notes payable, net of current portion | 396,722 | 468,108 | |||||||||
| Operating leases liabilities, net of current portion | 7,470 | 9,001 | |||||||||
| Contingent consideration, net of current portion | — | 10,590 | |||||||||
| Deferred tax liability | 10,378 | 10,370 | |||||||||
| Other non-current liabilities | 281 | 870 | |||||||||
| Total liabilities | 542,120 | 611,846 | |||||||||
| Commitments and contingencies—See Note 10 | |||||||||||
| Stockholders' equity: | |||||||||||
| Preferred stock, $0.0001 par value; 25,000,000 shares authorized and no shares issued or outstanding as of June 30, 2023 and December 31, 2022 | — | — | |||||||||
| Common stock, $0.0001 par value; 1,000,000,000 shares authorized | |||||||||||
| Issued and outstanding shares - 123,960,782 and 122,624,414 as of June 30, 2023 and December 31, 2022 | 12 | 12 | |||||||||
| Additional paid-in capital | 923,048 | 882,069 | |||||||||
| Accumulated deficit | (611,571) | (570,475) | |||||||||
| Accumulated other comprehensive income | 16,036 | 23,263 | |||||||||
| Total stockholders' equity | 327,525 | 334,869 | |||||||||
| Total liabilities and stockholders' equity | $ | 869,645 | $ | 946,715 | |||||||
| Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
| 2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||
| Revenue | $ | 171,512 | $ | 200,270 | $ | 324,673 | $ | 423,980 | |||||||||||||||
| Cost of revenue | 108,181 | 126,829 | 205,919 | 267,895 | |||||||||||||||||||
| Gross profit | 63,331 | 73,441 | 118,754 | 156,085 | |||||||||||||||||||
| Operating expenses: | |||||||||||||||||||||||
| Sales and marketing | 27,915 | 42,051 | 49,990 | 76,905 | |||||||||||||||||||
| General and administrative | 52,371 | 31,436 | 79,050 | 72,152 | |||||||||||||||||||
| Amortization of intangible assets | 8,888 | 8,888 | 17,777 | 17,777 | |||||||||||||||||||
| Change in fair value of contingent consideration | 1,765 | 255 | 2,808 | 1,955 | |||||||||||||||||||
| Goodwill impairment | — | 111,485 | — | 111,485 | |||||||||||||||||||
| Total operating expense | 90,939 | 194,115 | 149,625 | 280,274 | |||||||||||||||||||
| Loss from operations | (27,608) | (120,674) | (30,871) | (124,189) | |||||||||||||||||||
| Other income (expense): | |||||||||||||||||||||||
| Interest expense | (7,810) | (7,064) | (15,891) | (12,901) | |||||||||||||||||||
| Other income (expense), net | 5,450 | (5,350) | 6,028 | (4,806) | |||||||||||||||||||
| Total other expense | (2,360) | (12,414) | (9,863) | (17,707) | |||||||||||||||||||
| Loss before provision for income taxes | (29,968) | (133,088) | (40,734) | (141,896) | |||||||||||||||||||
| Provision for income taxes | 198 | 46 | 362 | 198 | |||||||||||||||||||
| Net loss | $ | (30,166) | $ | (133,134) | $ | (41,096) | $ | (142,094) | |||||||||||||||
| Net loss per share, basic and diluted | $ | (0.25) | $ | (1.13) | $ | (0.33) | $ | (1.20) | |||||||||||||||
| Weighted average common shares outstanding, basic and diluted | 123,027,759 | 118,211,168 | 122,864,345 | 118,051,090 | |||||||||||||||||||
| Other comprehensive income (loss): | |||||||||||||||||||||||
| Foreign currency translation adjustments | $ | 35 | $ | 12 | $ | 3 | $ | 9 | |||||||||||||||
| Change in cash flow hedge | — | 5,735 | (2,088) | 12,324 | |||||||||||||||||||
| Amortization of dedesignated cash flow hedge | (2,769) | — | (5,142) | — | |||||||||||||||||||
| Total other comprehensive income (loss) | (2,734) | 5,747 | (7,227) | 12,333 | |||||||||||||||||||
| Comprehensive loss | $ | (32,900) | $ | (127,387) | $ | (48,323) | $ | (129,761) | |||||||||||||||
| Six Months Ended June 30, | |||||||||||
| 2023 | 2022 | ||||||||||
| CASH FLOWS FROM OPERATING ACTIVITIES | |||||||||||
| Net loss | $ | (41,096) | $ | (142,094) | |||||||
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | |||||||||||
| Depreciation of property, plant and equipment | 7,462 | 6,023 | |||||||||
| Amortization of intangible assets | 21,378 | 21,337 | |||||||||
| Amortization of deferred financing costs | 1,026 | 979 | |||||||||
| Loss on disposal of property, plant and equipment | 1,689 | 1,176 | |||||||||
| Stock-based compensation expense | 40,979 | 27,434 | |||||||||
| Bad debt expense | 189 | (127) | |||||||||
| Unrealized loss (gain) on derivative contracts | (2,066) | 2,864 | |||||||||
| Amortization of dedesignated cash flow hedge | (5,142) | — | |||||||||
| Change in fair value of contingent consideration | 2,588 | (1,325) | |||||||||
| Goodwill impairment | — | 111,485 | |||||||||
| Other non-cash adjustments | (17) | — | |||||||||
| Change in operating assets and liabilities: | |||||||||||
| Accounts receivable | (40,979) | (18,709) | |||||||||
| Inventories, net | 55,668 | (17,781) | |||||||||
| Prepaid expenses and other current assets | (1,074) | (2,394) | |||||||||
| Other non-current assets | (13) | 23 | |||||||||
| Accounts payable and accrued expenses | (14,154) | (18,954) | |||||||||
| Other non-current liabilities | (582) | 13 | |||||||||
| Net cash provided by (used in) operating activities | 25,856 | (30,050) | |||||||||
| CASH FLOWS FROM INVESTING ACTIVITIES | |||||||||||
| Purchase of property, plant, and equipment | (8,854) | (12,422) | |||||||||
| Capitalization of patent costs | (223) | (305) | |||||||||
| Proceeds from sale of property, plant, and equipment | 2,450 | — | |||||||||
| Net cash used in investing activities | (6,627) | (12,727) | |||||||||
| CASH FLOWS FROM FINANCING ACTIVITIES | |||||||||||
| Proceeds from line of credit | 86,500 | 110,600 | |||||||||
| Repayments on line of credit | (130,209) | (73,927) | |||||||||
| Proceeds from long-term debt | — | 12,500 | |||||||||
| Repayments of long-term debt | (103) | — | |||||||||
| Principal payments on capital lease obligations | (251) | (217) | |||||||||
| Payment of acquisition related contingent consideration | (12,225) | (9,275) | |||||||||
| Taxes paid related to net share settlement of equity awards | — | (41) | |||||||||
| Net cash provided by (used in) financing activities | (56,288) | 39,640 | |||||||||
| Net decrease in cash, cash equivalents and restricted cash | (37,059) | (3,137) | |||||||||
| Cash, cash equivalents and restricted cash at beginning of period | 51,555 | 16,740 | |||||||||
| CASH AND CASH EQUIVALENTS AT END OF PERIOD | $ | 14,496 | $ | 13,603 | |||||||
| (Continued) | Six Months Ended June 30, | ||||||||||
| 2023 | 2022 | ||||||||||
| SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION: | |||||||||||
| Cash paid during the period for interest | $ | 20,487 | $ | 11,781 | |||||||
| Cash paid for income taxes | $ | 1,576 | $ | 1,988 | |||||||
| NON-CASH FINANCING AND INVESTING ACTIVITIES | |||||||||||
| Equipment purchased under finance leases | $ | 383 | $ | 344 | |||||||
| Property, plant, and equipment included in accounts payable and accrued expenses | $ | 1,813 | $ | 8,736 | |||||||
| Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
| 2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||
| (dollars in thousands, except share and per share amounts) | |||||||||||||||||||||||
Net loss | $ | (30,166) | $ | (133,134) | $ | (41,096) | $ | (142,094) | |||||||||||||||
| Adjustments: | |||||||||||||||||||||||
Other (income) expense (1) | (9,298) | 3,401 | (10,658) | 4,075 | |||||||||||||||||||
| Goodwill impairment | — | 111,485 | — | 111,485 | |||||||||||||||||||
| Stock-based compensation | 33,036 | 11,951 | 40,979 | 27,434 | |||||||||||||||||||
Non-routine legal expenses (2) | 248 | 1,051 | 481 | 2,969 | |||||||||||||||||||
Amortization of acquisition intangibles (3) | 8,253 | 8,253 | 16,507 | 16,507 | |||||||||||||||||||
| Change in fair value of contingent consideration | 1,765 | 255 | 2,808 | 1,955 | |||||||||||||||||||
Other adjustment items (4) | 526 | 668 | 669 | 1,081 | |||||||||||||||||||
Tax impact of adjusting items (5) | (46) | — | 106 | — | |||||||||||||||||||
| Adjusted net income | $ | 4,318 | $ | 3,930 | $ | 9,796 | $ | 23,412 | |||||||||||||||
Net loss | $ | (30,166) | $ | (133,134) | $ | (41,096) | $ | (142,094) | |||||||||||||||
| Adjustments: | |||||||||||||||||||||||
| Provision for income taxes | 198 | 46 | 362 | 198 | |||||||||||||||||||
| Interest expense | 7,810 | 7,064 | 15,891 | 12,901 | |||||||||||||||||||
| Depreciation and amortization | 14,587 | 14,242 | 28,841 | 27,419 | |||||||||||||||||||
Other (income) expense (6) | (6,529) | 3,401 | (5,516) | 4,075 | |||||||||||||||||||
| Goodwill impairment | — | 111,485 | — | 111,485 | |||||||||||||||||||
| Stock-based compensation | 33,036 | 11,951 | 40,979 | 27,434 | |||||||||||||||||||
Non-routine legal expenses (2) | 248 | 1,051 | 481 | 2,969 | |||||||||||||||||||
| Change in fair value of contingent consideration | 1,765 | 255 | 2,808 | 1,955 | |||||||||||||||||||
Other adjustment items (4) | 526 | 668 | 669 | 1,081 | |||||||||||||||||||
| Adjusted EBITDA | $ | 21,475 | $ | 17,029 | $ | 43,419 | $ | 47,423 | |||||||||||||||
| Revenue | $ | 171,512 | $ | 200,270 | $ | 324,673 | $ | 423,980 | |||||||||||||||
| Net loss margin | (17.6) | % | (66.5) | % | (12.7) | % | (33.5) | % | |||||||||||||||
| Adjusted net income margin | 2.5 | % | 2.0 | % | 3.0 | % | 5.5 | % | |||||||||||||||
| Adjusted EBITDA margin | 12.5 | % | 8.5 | % | 13.4 | % | 11.2 | % | |||||||||||||||
| Net loss per diluted share | $ | (0.25) | $ | (1.13) | $ | (0.33) | $ | (1.20) | |||||||||||||||
| Adjusted net income per diluted share | $ | 0.04 | $ | 0.03 | $ | 0.08 | $ | 0.20 | |||||||||||||||
| Weighted average common shares outstanding - diluted | 123,027,759 | 118,211,168 | 122,864,345 | 118,051,090 | |||||||||||||||||||